Collegium Pharmaceutical’s (COLL) “Neutral” Rating Reiterated at Piper Sandler

Дата публикации: 10-08-2026 05:48:46

Piper Sandler restated their neutral rating on shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) in a report published on Friday morning,Benzinga reports. Piper Sandler currently has a $43.00 target price on the specialty pharmaceutical company’s stock, down from their previous target price of $45.00. Other research analysts have also issued reports about the company. […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Piper Sandler Cuts Molson Coors Beverage (NYSE:TAP) Price Target to $44.00	0	9.52	10-08-2026
2	Piper Sandler Cuts Celsius (NASDAQ:CELH) Price Target to $36.00	0	12.64	10-08-2026
3	BP (NYSE:BP) Price Target Raised to $43.00	0	12.22	10-08-2026
4	Definium Therapeutics’ (DFTX) “Overweight” Rating Reiterated at Piper Sandler	0	8.75	10-08-2026
5	Piper Sandler Cuts ResMed (NYSE:RMD) Price Target to $225.00	0	10.45	10-08-2026
6	Piper Sandler Cuts Papa John’s International (NASDAQ:PZZA) Price Target to $26.00	0	11.89	10-08-2026
7	Piper Sandler Cuts Abacus Global Management (NYSE:ABX) Price Target to $12.00	0	10.81	10-08-2026
8	Sotera Health’s (SHC) Overweight Rating Reiterated at Piper Sandler	0	9.05	10-08-2026
9	Shoulder Innovations’ (SI) Overweight Rating Reiterated at Piper Sandler	0	8.45	10-08-2026
10	Teleflex’s (TFX) Overweight Rating Reiterated at Piper Sandler	0	10.31	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.68. Источник: www.americanbankingnews.com.